(Q28342625)

English

BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-β-hydroxylase with antihypertensive activity

scientific article (publication date: May 1976)

In more languages

Statements

scholarly article

0 references

BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-beta-hydroxylase with antihypertensive activity (English)

0 references

BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-β-hydroxylase with antihypertensive activity (English)

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

0 references

0 references

author name string

I. M. Claxton

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1278239

8 September 2022

M. G. Palfreyman

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1278239

8 September 2022

R. H. Poyser

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1278239

8 September 2022

R. L. Whiting

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1278239

8 September 2022

language of work or name

0 references

publication date

May 1976

0 references

full work available at URL

https://api.elsevier.com/content/article/PII:0014299976900200?httpAccept=text/xml

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

https://api.elsevier.com/content/article/PII:0014299976900200?httpAccept=text/plain

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

European Journal of Pharmacology

0 references

37

0 references

1

0 references

179-88

0 references

Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.

1

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY DISULFIRAM

4

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

The effect of disulfiram on the biosynthesis of catecholamines during exposure of rats to cold

6

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Self-sustaining, post-DCA hypertensive cardiovascular disease.

7

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Fusaric (5-Butylpicolinic) Acid, an Inhibitor of Dopamine β-Hydroxylase, affects Serotonin and Noradrenaline

8

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Fusaric acid, a hypotensive agent produced by fungi

9

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.

10

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

2-mercaptobenzothiazole, an inhibitor of dopamine beta-hydroxylase.

14

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Inhibition of norepinephrine synthesis in mouse brain by blockade of dopamine-β-oxidase

17

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

18

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Dopamine-ß-hydroxylase inhibition by dimethyldithiocarbamate and related compounds

19

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

EFFECTS OF DISULFIRAM ON TISSUE NOREPINEPHRINE CONTENT AND SUBCELLULAR DISTRIBUTION OF DOPAMINE, TYRAMINE AND THEIR BETA-HYDROXYLATED METABOLITES

22

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Inhibition of dopamine β-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo

23

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas

24

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Inhibition of dopamine beta-hydroxylase by 5-alkylpicolinic acid and their hypotensive effects

25

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.

26

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

On the significance of central noradrenaline for motor activity: Experiments with a new dopamine β-hydroxylase inhibitor

27

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Effect of dopamine-β-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of l-dopa

28

1 reference

10.1016/0014-2999(76)90020-0

https://api.crossref.org/works/10.1016/0014-2999(76)90020-0

20 November 2023

Identifiers

10.1016/0014-2999(76)90020-0

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28342625&oldid=2014387279"